Lisa Bright
medical
Intercept
Ireland
Biography
Lisa Bright is our President, International. She has over 25 years of experience in the biopharmaceutical industry. Ms. Bright previously served as our Chief Commercial and Corporate Affairs officer from February 2015 through July 2016 and joined Intercept in November 2014 as the Head of Europe. Prior to joining Intercept, Ms. Bright worked at Gilead Sciences Ltd. starting in 2008, where she held positions of increasing responsibility, including: general manager United Kingdom & Ireland; vice president, Northern Europe; vice president, head of Sovaldi launch planning for Europe, Asia, Middle East and Australasia; and vice president, government affairs Europe, Middle East and Australasia. Prior to holding these positions, Ms. Bright held a range of senior positions at GlaxoSmithKline plc, including vice president and managing director of New Zealand and vice president — sales for the United Kingdom. Ms. Bright has a B.Sc. in pharmacology from University College London.
Research Interest
research and development